Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
1(20%)
Results Posted
75%(3 trials)

Phase Distribution

Ph phase_2
1
20%
Ph phase_4
2
40%
Ph not_applicable
1
20%
Ph phase_1
1
20%

Phase Distribution

1

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
1(20.0%)
Phase 4Post-market surveillance
2(40.0%)
N/ANon-phased studies
1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(4)

Detailed Status

Completed4
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (20.0%)
Phase 21 (20.0%)
Phase 42 (40.0%)
N/A1 (20.0%)

Trials by Status

completed480%
active_not_recruiting120%

Recent Activity

1 active trials
Showing 5 of 5
active_not_recruitingphase_4

A Study to Evaluate Preemptive Therapy in Hepatitis C (HCV) Organ Transplant Recipients

NCT04508907
completedphase_1

Transplanting Hepatitis C Kidneys Into Negative Kidney Recipients

NCT02743897
completednot_applicable

Providing PrEP, Hepatitis C Treatment, and MOUD Through Telemedicine at Greensboro SSP

NCT05108935
completedphase_4

Viekira Pak or Mavyret Treatment for Patient With Chronic Kidney Disease and Hepatitis C

NCT02946034
completedphase_2

A Study of the Use of Hepatitis C Positive Donors for Hepatitis C Negative Lung Transplant Recipients With Post-transplant Treatment With Mavyret

NCT03523871

Clinical Trials (5)

Showing 5 of 5 trials
NCT04508907Phase 4

A Study to Evaluate Preemptive Therapy in Hepatitis C (HCV) Organ Transplant Recipients

Active Not Recruiting
NCT02743897Phase 1

Transplanting Hepatitis C Kidneys Into Negative Kidney Recipients

Completed
NCT05108935Not Applicable

Providing PrEP, Hepatitis C Treatment, and MOUD Through Telemedicine at Greensboro SSP

Completed
NCT02946034Phase 4

Viekira Pak or Mavyret Treatment for Patient With Chronic Kidney Disease and Hepatitis C

Completed
NCT03523871Phase 2

A Study of the Use of Hepatitis C Positive Donors for Hepatitis C Negative Lung Transplant Recipients With Post-transplant Treatment With Mavyret

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5